JPH025426B2 - - Google Patents
Info
- Publication number
- JPH025426B2 JPH025426B2 JP56173638A JP17363881A JPH025426B2 JP H025426 B2 JPH025426 B2 JP H025426B2 JP 56173638 A JP56173638 A JP 56173638A JP 17363881 A JP17363881 A JP 17363881A JP H025426 B2 JPH025426 B2 JP H025426B2
- Authority
- JP
- Japan
- Prior art keywords
- tube
- weight
- styrene
- chlorinated polyethylene
- thermoplastic resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004709 Chlorinated polyethylene Substances 0.000 claims description 23
- 229920005992 thermoplastic resin Polymers 0.000 claims description 18
- 229920003048 styrene butadiene rubber Polymers 0.000 claims description 14
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 11
- 239000000460 chlorine Substances 0.000 claims description 11
- 229910052801 chlorine Inorganic materials 0.000 claims description 11
- 239000002174 Styrene-butadiene Substances 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 6
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 6
- 239000011115 styrene butadiene Substances 0.000 claims description 6
- 238000002835 absorbance Methods 0.000 claims description 5
- 238000000465 moulding Methods 0.000 claims description 4
- 229920001684 low density polyethylene Polymers 0.000 claims description 3
- 239000004702 low-density polyethylene Substances 0.000 claims description 3
- 229920005604 random copolymer Polymers 0.000 claims description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 15
- 239000004800 polyvinyl chloride Substances 0.000 description 15
- 239000004014 plasticizer Substances 0.000 description 11
- 238000005452 bending Methods 0.000 description 10
- 238000002156 mixing Methods 0.000 description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 239000005038 ethylene vinyl acetate Substances 0.000 description 5
- 238000004388 gamma ray sterilization Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000005062 Polybutadiene Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920002857 polybutadiene Polymers 0.000 description 4
- 229920000098 polyolefin Polymers 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- -1 polyethylene chain Polymers 0.000 description 3
- 229920001195 polyisoprene Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920010126 Linear Low Density Polyethylene (LLDPE) Polymers 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
çºæã®èæ¯
æè¡åé
æ¬çºæã¯ãå»çšããŠãŒãã«é¢ãããããã«è©³ã
ãã¯ãåçš®å»ççšå
·ã«çšããããããŠãŒãã®æ¹è¯
ã«é¢ããã
å
è¡æè¡ãšãã®åé¡ç¹
åŸæ¥ãå»çšããŠãŒããšããŠã¯ãè»è³ªããªå¡©åã
ãã«è£œã®ãã®ãæ±çšãããŠããã茞液ã茞è¡ç®¡ã
人工è
èçšåè·¯ãã«ããŒãã«ççš®ã
ã®å»ççšå
·ã«
çšããããŠããã
ããã¯è»è³ªããªå¡©åããã«ããå å·¥æ§ãæ¥çæ§
ã«ããããå»ççšå
·ãçµç«ãŠãäžã§åãæ±ããã
ãäžãå¯å¡å€ãä»»æã«é
åã§ããããå¯ãšãæ§ã®
調æŽã容æã§ããããã§ããã
ããããè»è³ªããªå¡©åããã«ã«ãå¯å¡å€ãå«æ
ããããããå»çšããŠãŒãã«çšãããšãè¡æ¶²ãè¬
液çã«å¯å¡å€ã溶åºã移è¡ããå±éºæ§ãããã
åŸæ¥ãå¯å¡å€ã®ç§»è¡é²æ¢ã®ããã«ãããªå¡©åã
ãã«ã·ãŒãã«ãã©ãºãåŠçãæœãæè¡ãç¥ãããŠ
ããããããããã®ãããªæè¡ã¯ãããŠãŒãã®å
é¢ã«ã¯ãå®çšçã«é©çšã§ããªãã
ãã®ãããå»çšããŠãŒãã圢æããæ質ã¯ãå¯
å¡å€ãå«ãŸãªããã®ã«ãããå¿
èŠãããã
ãã®å Žåãå¯ãšãæ§ã«å¯ã¿ãå¯å¡å€ãå¿
èŠãšã
ãªãæ質ãšããŠãã·ãªã³ãŒã³ããŠãŒãçã®ããã
ããã«ãç¥ãããŠããããããããããã¯ããã
ããæŒåºå å·¥ãã§ããã管ç¶ã«åœ¢æããäžã§ã³ã¹
ããé«ããªãããŸããæ¥çå€ãé«åšæ³¢æº¶èçã«ã
ãæ¥çãã§ãããäºæ¬¡å å·¥ãã§ãããåçš®å»ççš
å
·ãžã®çµç«ãŠãããããŠå°é£ã§ãããå ããŠãé«
䟡ã§ããã
ããã«å¯Ÿããåçš®ãªã¬ãã€ã³ç³»ããªããŒè£œã®ã
ãŠãŒããç¥ãããŠãããããããå»çšããŠãŒããš
ããŠçšãããšãã«ã¯ããã¯ãæ¥çæ§ã«æ¬ ããä»ã
å¯ãšãæ§ã«å£ããæ²ããããããšããããŸãããŠ
ãŒãèªäœãå±æ²ã«éãæããŠããŸãã液ãªã©ã®é
å¡ãèµ·ã€ãŠããŸãã
çºæã®ç®ç
æ¬çºæã¯ããã®ãããªå®ç¶ã«éã¿ãªããããã®
ã§ãã€ãŠããã®äž»ããç®çã¯ãåŸæ¥ã®è»è³ªããªå¡©
åããã«è£œã®å»çšããŠãŒãã®ç¹æ§ãç¹ã«å¯ãšãæ§
ãããã¯å å·¥æ§ãæ¥çæ§çãåç以äžãªãã®ãšã
ãªããã溶åºç©ã®ãªãå»çšããŠãŒããæäŸããã
ãšã«ãããããå
·äœçã«ã¯ãå¯å¡å€çã®æ·»å å€ã
å«ãŸãã溶åºç©ããªãããããå¯ãšãæ§ã«ãã
ããããŠãŒãæããããããŠå°ãªããå€åœ¢åŸã®åŸ©
å
æ§ã«ããããããã«æŒåºãå å·¥å¯èœã§ãæ¥çæ§
ãäºæ¬¡å å·¥æ§ã«ãããããéææ§ãè¯å¥œã§ããç
ã®ãç·åçã«ã¿ãŠããããŠè¯å¥œãªç¹æ§ããã€å»çš
ããŠãŒããæäŸããããšã§ããã
æ¬çºæè
ãã¯ããã®ãããªç®çã«ã€ãéæç 究
ãããããããçµæãæ¬çºæããªãã«è³ã€ããã®
ã§ããã
ããªãã¡æ¬çºæã¯ãå¡©çŽ å«éãééæ¯ã§25ã45
ïŒ
ã®å¡©çŽ åããªãšãã¬ã³ãšãäœå¯åºŠããªãšãã¬
ã³ãã¹ãã¬ã³âãã¿ãžãšã³ã©ã³ãã å
±éåäœãã¹
ãã¬ã³âãã¿ãžãšã³ãããã¯å
±éåäœãã¹ãã¬ã³
âãã¿ãžãšã³ãã¬ãããã¯å
±éåäœããã³é
¢é
žã
ãã«å«æé30wtïŒ
以äžã®ãšãã¬ã³âé
¢é
žããã«
å
±éåäœããéžã°ããå°ãªããšãïŒã€ã®ç±å¯å¡æ§
æš¹èãšã®ãã¬ã³ãããªããŒã管ç¶ã«æ圢ããŠãªã
å»çšããŠãŒãã§ãã€ãŠã
å¡©çŽ åããªãšãã¬ã³100éééšããã10ã50é
ééšã®åèšç±å¯å¡æ§æš¹èãé
åããŠãªããå®è³ªç
ã«æ·»å å€ãå«ãŸãããããåæ匟æ§çãïŒKgïŒmm2
以äžã§ããã€åžžæž©ã«æ¯ããŠïŒâã§ã®æãã®çãã
æ²çãå€åããªãç©æ§ã§ããããšãç¹åŸŽãšããå»
çšããŠãŒãã§ããã
çºæã®å
·äœçæ§æ
以äžãæ¬çºæã®å
·äœçæ§æã«ã€ããŠè©³çŽ°ã«èª¬æ
ããã
æ¬çºæã®å»çšããŠãŒãã¯å¡©çŽ åããªãšãã¬ã³ãš
ãã®ä»ã®ç±å¯å¡æ§æš¹èãšã®ãã¬ã³ãããªããŒãã
ãªãã
ãã¬ã³ãã«çšããå¡©çŽ åããªãšãã¬ã³ã¯ãç¹
ã«ãäžå¯åºŠãªããé«å¯åºŠã®ããªãšãã¬ã³ãåžžæ³ã«
åŸãå¡©çŽ åãããã®ã§ãããå¡©çŽ ã¯ãããªãšãã¬
ã³éäžã«ã©ã³ãã ã«çµåãããã®å¡©çŽ å床ãããª
ãã¡å¡©çŽ å«éãšããŠã¯ãééæ¯ã§ã25ã45ïŒ
ãã
ã奜ãŸããã¯30ã40ïŒ
ã§ããã
ãã®ãããªå¡©çŽ å«éã§ã¯ãè»è³ªããªå¡©åããã«
ãšæ¯èŒããŠãå¯ãšãæ§ãäžå±€åäžããããŠãŒãæ
ããæ Œæ®µãšæžå°ãããŸãå€åœ¢åŸã®åŸ©å
æ§ãæ Œæ®µãš
åäžããããŸããäœæž©ã§ã®å¯ãšãæ§ãèè¡ææ§ã
è»è³ªããªå¡©åããã«ãšæ¯èŒããŠæ Œæ®µãšåäžããã
ãŸããçšããå¡©çŽ åããªãšãã¬ã³ã®ååéãšã
ãŠã¯ãç¹ã«å¶éã¯ãªãããæ°å¹³åååéã§ãæŠã
ïŒäžã30äžçšåºŠã®ãã®ãçšããã°ããã
ãŸãããã®ååžã«ãç¹ã«å¶éã¯ãªãã
ããã«ãå¯åºŠãšããŠã¯ãéåžžã1.00ã1.25çšåºŠ
ã®ãã®ãçšããã°ããã
ä»æ¹ããã¬ã³ãã«çšããå¡©çŽ åããªãšãã¬ã³ä»¥
å€ã®ä»ã®ç±å¯å¡æ§æš¹èãšããŠã¯ãçš®ã
ã®ãã®ãïŒ
çš®ãŸãã¯ãã以äžçšããããšãã§ããã
ãã®ãã¡ãããªãªã¬ãã€ã³ããªã¬ãã€ã³å
±éå
äœããã³ã¹ãã¬ã³å
±éåäœã¯ãããã«ãããä»ã®
ç±å¯å¡æ§æš¹èãšããŠãç¹ã«å¥œé©ã§ãããããã¯ã
ãããã®ïŒçš®ãŸãã¯ãã以äžããåèšå¡©çŽ åããª
ãšãã¬ã³ãšãã¬ã³ããããšããå¯ãšãæ§ããã³é
ææ§ã®ç¹ã§ãããããŠå¥œãŸããç¹æ§ãåŸãããã
ãã§ããã
ãã®ãããªæš¹èã®ãã¡ãç¹ã«å¥œé©ãªå
·äœäŸã瀺
ãã°ã以äžã®ãããªãã®ãããã
(A) äœå¯åºŠããªãšãã¬ã³ããã®ãã¡ç¹ã«ãªãã€äœ
å¯åºŠããªãšãã¬ã³ïŒLLDPEïŒã
å¯åºŠã¯0.915ã0.940ãASTM â1238ã«ã
ãšã¥ãã¡ã«ãã»ã€ã³ããã¯ã¹ïŒïœïŒ10å以äžã®
ãã®ã¯ç¹ã«å¥œãŸããã
(B) ãšãã¬ã³âé
¢é
žããã«å
±éåäœïŒEVAïŒ
é
¢é
žããã«ïŒVAïŒå«æé30wtïŒ
以äžãç¹ã«
ïŒã25wtïŒ
ãå¯åºŠ0.915ã0.95ãæ°å¹³åååé
ïŒäžã20äžãã¡ã«ãã»ã€ã³ããã¯ã¹ïŒïœïŒ10å
以äžã®ãã®ãç¹ã«å¥œãŸããã
(C) ã¹ãã¬ã³å
±éåäœãç¹ã«ã¹ãã¬ã³âãã¿ãžãš
ã³å
±éåäœ
ïŒ ã¹ãã¬ã³âãã¿ãžãšã³ã©ã³ãã å
±éåäœ
ïŒSBRïŒ
ã¹ãã¬ã³å«æé20ã40ïŒ
çšåºŠãæ°å¹³ååå
é20äžçšåºŠãã ãŒããŒç²åºŠ20ã60çšåºŠã®ãã®
ãç¹ã«å¥œãŸããã
ïŒ ã¹ãã¬ã³âãã¿ãžãšã³ãããã¯å
±éåäœ
ïŒSBïŒ
ãœããã»ã°ã¡ã³ããšããŠãããªãã¿ãžãšã³
ããã³ããªã€ãœãã¬ã³ãããªãããããšãã
ãã¯å
±éåãããããæ«ç«¯ã«ååšããããªã¹
ãã¬ã³ããŒãã»ã°ã¡ã³ããããªããã®ã
ãã®å Žåãå¯åºŠ0.94ã0.95ãã¡ã«ãã»ã€ã³
ããã¯ã¹ïŒïœïŒ10å以äžã®ãã®ã奜ãŸããã
ïŒ ã¹ãã¬ã³âãã¿ãžãšã³ãã¬ãããã¯å
±éå
äœïŒSBSïŒ
ãœããã»ã°ã¡ã³ããšããŠãããªãã¿ãžãš
ã³ãããªã€ãœãã¬ã³ããã³ããªãªã¬ãã€ã³ã
ããªãããããšãããã¯å
±éåãããããäž¡
æ«ç«¯ã«ååšããããªã¹ãã¬ã³ããŒãã»ã°ã¡ã³
ããããªããã®ããã®å Žåãå¯åºŠ0.90ã
0.94ãã¡ã«ãã»ã€ã³ããã¯ã¹10ïœïŒ10å以äž
ã®ãã®ã奜ãŸããã
ãã®ãããªãã¬ã³ããããå¡©çŽ åããªãšãã¬ã³
以å€ã®ä»ã®ç±å¯å¡æ§æš¹èã¯ããã¬ã³ãããªããŒã®
éææ§ã®ç¹ããããã®å±æçãæŠã1.48ã1.52çš
床ã§ããããšã奜ãŸããããã®ãããªå¡©çŽ åããª
ãšãã¬ã³ãšãä»ã®ç±å¯å¡æ§æš¹èãšã®ãã¬ã³ãé
å
æ¯ã¯ãå¡©çŽ åããªãšãã¬ã³100éééšããããç±
å¯å¡æ§æš¹è10ã50éééšãšããããšã奜ãŸããã
10ã50éééšãšãªããšãå¯ãšãæ§ãäœæž©ç¹æ§ã
è¯å¥œãšãªãã
ãã®å Žåãé
åæ¯ããå¡©çŽ åããªãšãã¬ã³100
éééšããããïŒã100éééšããã奜ãŸããã¯
10ã50éééšãšãªããšãå¯ãšãæ§ãäœæž©ç¹æ§ã¯ã
ãã«è¯å¥œãšãªãã
ãããŠããã®ãããªé
åæ¯ã§ãåžžæ³ã«åŸããã¬
ã³ããããŠããã¬ã³ãããªããŒãšãããã
ãã®ãããªå¡©çŽ åããªãšãã¬ã³ãšããã®ä»ã®ç±
å¯å¡æ§æš¹èãããªããã¬ã³ãããªããŒã¯ãæ圢ã
ããŠç®¡ç¶ã®ããŠãŒãããªãã
ãã®å Žåãæ圢ãããããŠãŒãã®åæ匟æ§çã¯
ïŒKgïŒmm2以äžã§ããã
ããã«ãåæ匟æ§çã¯ãå€åœ¢âå¿åæ²ç·ã®å€
圢é埮å°ç¯å²ã®ç«äžãéšã«ãããŠãJIS  7113
ã«åŸããïŒïŒ·ã»ïœïŒâ³ïœã»ïŒ¡ãããã«ãã¯å°
å è·éïŒKgïŒãïœã¯åœåã®é·ãïŒmmïŒãâ³ïœã¯äŒžã³
ïŒmmïŒãã¯æé¢ç©ïŒmm2ïŒã§ãããã«ãã€ãŠç®åºã
ããã
ãããŠãåæ匟æ§çãïŒKgïŒmm2以äžãšãªããšã
å¯ãšãæ§ãæ Œæ®µãšåäžããããŠãŒãæããæžå°
ãã埩å
æ§ãåäžããããŸããäœæž©ç¹æ§ãç¹ã«äœ
æž©ã§ã®å¯ãšãæ§ãšèè¡ææ§ãåäžããããã®å Ž
åãåæ匟æ§çã¯0.1ã4.0KgïŒmm2ã®ç¯å²ã§ããã
ãšããå¯ãšãæ§çã®ç¹ã§ãã€ãšã奜é©ã§ããã
ãªããïŒKgïŒmm2以äžã®åæ匟æ§çã«èª¿æŽããã«
ã¯ãå¡©çŽ åããªãšãã¬ã³ã®å¡©çŽ å«æéãååéã
çµæ¶æ§ããããã¯ä»ã®ç±å¯å¡æ§æš¹èã®çš®é¡ãé
å
æ¯çãããã容æã«ãã®æ¡ä»¶ãå®éšçã«æ±ããã
ãšãã§ããã
ããã«ãããŠãŒãã¯éææ§ã®ç¹ã§ãïŒmmåãã
ãã500nïœã«ãããåžå
床ãã0.18ã0.65ã§ãã
ããšã奜ãŸããã
äžæ¹ãæ圢ã«éããŠã¯ãäžèšãã¬ã³ãããªããŒ
ã«ã¯ãå¯å¡å€çã®æ·»å å€ãæ·»å ããå¿
èŠããªãã
ãã®ãããããŠãŒãå
å£ããã®æº¶åºã¯ã»ãšãã©ãª
ãã
ä»æ¹ãæ圢ã¯ãéåžžã®æŒåºãå å·¥ã«ãã€ãŠè¡ã
ããšãã§ããããã®ãããæ圢å å·¥ã¯ããããŠå®¹
æãšãªããã³ã¹ãã¯äœããªãããã®å ŽåãæŒåºã
æ圢æ©äžã®ã¹ã¯ãªãŠãŒã§ãã©ã€ãã¬ã³ããè¡ã
ã°ã補é ã¯ãã容æãšãªãã
ãã®ããã«æ圢ãããããŠãŒãã¯ãéåžžãå
åŸ
ïŒã20mmçšåºŠããŸãèå0.3ã3.5mmçšåºŠãšãã
ãããããŠããã®ãããªå¯žæ³ã«ãããŠãããããŠ
è¯å¥œãªå¯ãšãæ§ã瀺ããã®ã§ããã
ãªãããã®æé¢åœ¢ç¶ã寞æ³çã¯çš®ã
ã®ãã®ãšã
ãããšãã§ããã
ãã®ãããªæ¬çºæã®å»çšããŠãŒãã¯ã茞液ã»ã
ãã茞è¡ã»ããçã®é£çµç®¡ãéæè£
眮ã人工è
è
çã®åçš®äœå€åŸªç°åè·¯äžã®äœæ¶²ãªããè¡æ¶²åè·¯çš
ããŠãŒããåçš®ç眮éçšããŠãŒããåçš®ã«ããŒã
ã«çãããã«ã¯åŒåžåè·¯çšããŠãŒãçãšããŠçšã
ãããã
ãããŠããããã®åçš®å»ççšå
·ã¯ãæ¬çºæã®å»
çšããŠãŒããæå®ã®é
眮ã§ä»ã®æ§æéšåãšé«åšæ³¢
æ¥çãããããŠããŸããã®ä»ã®ææã®ïŒæ¬¡å å·¥ã
ãããããŠãçµç«ãŠãããã
çºæã®å
·äœçå¹æ
æ¬çºæã®å»çšããŠãŒãã¯ãå¡©çŽ åããªãšãã¬ã³
ãšãä»ã®ç±å¯å¡æ§æš¹èãšã®ãã¬ã³ãããªããŒãã
ãªããããªå¡©åããã«ã®ããã«å¯å¡å€çã®æ·»å å€
ã®æ·»å ãå¿
èŠãšããªãã®ã§ãå
å£ããäœæ¶²ãè¡
液ãè¬æ¶²çãžã®æº¶åºãããããŠå°ãªãã
ãŸããè»è³ªããªå¡©åããã«ãããããããå¯ãš
ãæ§ã瀺ããããªãã¡ãããŠãŒãæãã¯ããããŠ
å°ãªããããŠãŒãæãã®çããæ²ãæ²çååŸã¯ã
ãªå¡©åããã«ãšæ¯èŒããŠããããŠå°ããããŸãã
å€åœ¢ã«å¯Ÿãã埩å
æ§ãè¯å¥œã§ãäŸãã°ãã¯ã¬ã³ã¡
ã§æŸçªãããããªãšããæŸçªéé€åŸãçŽã¡ã«åŸ©å
ãããŸãæŸçªã«å¯Ÿããè¿œéæ§ãæµææ§ãšãè¯å¥œ
ã§ãããªå¡©åããã«ãšæ¯èŒããŠãå®æµéæ§ã«ãã
ããŠããã
ããã«ã¯ãäœæž©ã«ãŠãé·æéä¿åãããããªãš
ãããããã¯äœæž©æã«ãããŠãããªå¡©åããã«ã¯
å¯ãšãæ§ãäœäžããããæ¬çºæã®ããŠãŒãã¯ãæ
ããå°ãªããå®æµéæ§ãè¯å¥œã§ããããŸãèè¡æ
æ§ãé«ãã
ãããŠããã®ãããªå¯ãšãæ§ããã³äœæž©ç¹æ§
ã¯ãå¡©çŽ åããªãšãã¬ã³åç¬äœãããè¯å¥œã§ã
ãã
å ããŠãæ»
èåŠçãšããŠããšãã¬ã³ãªããµã€ã
ã¬ã¹æ»
èãè¡ã€ããšããå¯å¡å€çã®æ·»å å€ãå«ãŸ
ãªãããšãããæ»
èåŸåžçããããšãã¬ã³ãªããµ
ã€ãã¬ã¹ã®è±ã¬ã¹é床ããè»è³ªããªå¡©åããã«ã«
æ¯èŒããŠéãã
ãŸããγâç·æ»
èã«å¯ŸããŠãæµææ§ããããã
ã®ç©æ§ã«å€åã¯ãªãã
ããã«ãæŒãåºãå å·¥ãè¯å¥œã«è¡ãããšãã§
ãã補é ã容æã§ããããããé«åšæ³¢èªé»å ç±ã
æ¥çå€ã«ããæ¥çãå¯èœã§ãæ¥çå å·¥ã容æã§ã
ããå ããŠå»ççšå
·ã«çµç«ãŠãéã®åçš®ïŒæ¬¡å å·¥
ã容æã«è¡ãããšãã§ããã
ãããŠãå¡©çŽ å«é30ã40ïŒ
ã®å¡©çŽ åããªãšãã¬
ã³ãçšããã°ãäžèšã®å¯ãšãæ§ã¯ããäžå±€è¯å¥œãš
ãªãã
ãã¬ã³ããããä»ã®ç±å¯å¡æ§æš¹èã®å±æçã
1.48ã1.52çšåºŠã§ãããããŠãŒãã®500nïœã«ãã
ãåžå
床ããïŒmmåãããã0.18ã0.65ãšãªãã
ããè¡æ¶²ããŠãŒããšããŠåãæ±ãå Žåéææ§ãè¯
奜ã§ããã
ããã«ãããŠãŒãå
åŸïŒã15mmã«ãããŠã¯ãæ
ãããã³å®æµéæ§ã®æ¹åå¹æãé¡èã§ããã
æ¬çºæè
ãã¯ãæ¬çºæã®å¹æã確èªããããã
çš®ã
å®éšãè¡ã€ãã以äžã«ãã®ïŒäŸã瀺ãã
å®éšäŸ ïŒ
æ°å¹³åååé10äžãå¯åºŠ0.95ã®é«å¯åºŠããªãšã
ã¬ã³ã®å¡©çŽ åãè¡ããå¡©çŽ å«é30ïŒ
ãå¯åºŠ1.13ã®
å¡©çŽ åããªãšãã¬ã³ïŒPEâClïŒãåŸãã
ä»æ¹ãä»ã®ç±å¯å¡æ§æš¹èãšããŠã¯ãåèšSBS
ïŒãœããã»ã°ã¡ã³ãïŒããªãã¿ãžãšã³ãããªã€ãœ
ãã¬ã³ãããªãªã¬ãã€ã³ãããŒãã»ã°ã¡ã³ãïŒã
ãªã¹ãã¬ã³ãå¯åºŠ0.93ãã¡ã«ãã»ã€ã³ããã¯ã¹10
ïœïŒ10åãïŒãçšãããã®PEâCl察SBSã®ééæ¯
ã80ïŒ20ã«ãªãããã«é
åããŠãæŒãåºãå å·¥æ©
ã®ããããŒã«æå
¥ããã¹ã¯ãªãŠãŒã·ãªã³ããŒå
ã§
130ã190âã«ãŠãã¬ã³ãããåŸããã€ãã190â
ã«ãŠãå
åŸïŒmmãå€åŸïŒmmã®é£ç¶ç®¡ç¶ã«æŒãåº
ããæ¬çºæã®ããŠãŒããäœè£œããã
ãããšã¯å¥ã«ãå
ã®PEâClåç¬ãããåæ§ã«
åäžå¯žæ³ã®ããŠãŒããäœè£œããã
ããã«ãå¯å¡å€ãå®å®å€ãå«ãè»è³ªããªå¡©åã
ãã«ïŒPVCïŒæ¥æ¬ãŒãªã³ç€Ÿè£œ 103EPïŒããã
åããæŒãåºãå å·¥ã«ãããåäžå¯žæ³ã®ããŠãŒã
ãäœè£œããã
ãŸããé
¢é
žããã«å«æé15wtïŒ
ã®ãšãã¬ã³â
é
¢é
žããã«å
±éåäœïŒEVAïŒæ±æŽæ¹éå·¥æ¥ç€Ÿè£œ
UEâ630ïŒãããåæ§ã«ãåäžå¯žæ³ã®ããŠãŒãã
äœæããã
ãããïŒçš®ã®ããŠãŒãã«ã€ããJIS  7113ã«
åŸããåæ匟æ§çã枬å®ãããçµæãè¡šïŒã«ç€º
ãã
ãªããè¡šïŒäžã«ã¯ãïŒçš®ã®ããŠãŒãã®500nïœ
ã«ããããïŒmmåã®åžå
床ã瀺ããããBACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to medical tubes. More specifically, the present invention relates to improvements in tubes used in various medical devices. Prior art and its problems Traditionally, medical tubes made of soft polyvinyl chloride have been widely used, and are used for infusions, transfusion vessels,
It is used in various medical devices such as artificial kidney circuits and catheters. This is because soft polyvinyl chloride has excellent processability and adhesive properties, is easy to handle when assembling medical devices, and can be mixed with a plasticizer arbitrarily, making it easy to adjust flexibility. However, if soft polyvinyl chloride contains a plasticizer and is used in a medical tube, there is a risk that the plasticizer will elute and migrate into blood, medical solutions, and the like. Conventionally, a technique is known in which a polyvinyl chloride sheet is subjected to plasma treatment in order to prevent plasticizer migration. However, such techniques cannot be practically applied to the inner surface of the tube. Therefore, the material forming the medical tube must be changed to one that does not contain plasticizers. In this case, excellent materials such as silicone tubes are known as materials that are highly flexible and do not require plasticizers. However, none of these materials can be extruded, resulting in high costs when formed into a tubular shape. Furthermore, they cannot be bonded with adhesives or high-frequency melting, and cannot be subjected to secondary processing, making them difficult to manufacture into various medical devices. Extremely difficult to assemble. In addition, it is expensive. On the other hand, tubes made of various olefin polymers are also known, but when used as medical tubes, they still lack adhesive properties and
It has poor flexibility and cannot be bent easily, and the tube itself may break when bent, resulting in blockage of liquid or the like. Purpose of the Invention The present invention was made in view of the above-mentioned circumstances, and its main purpose is to improve the characteristics of conventional medical tubes made of flexible polyvinyl chloride, particularly flexibility, workability, adhesiveness, etc. The object of the present invention is to provide a medical tube that is equivalent to or better than that and is free from eluates. More specifically, it does not contain additives such as plasticizers, has no eluates, has excellent flexibility, has very little tube bending, has excellent recovery properties after deformation, can be extruded, and has good adhesive properties. It is an object of the present invention to provide a medical tube having extremely good properties overall, such as excellent secondary processability and good transparency. The inventors of the present invention have repeatedly and diligently researched for this purpose, and as a result, they have arrived at the present invention. That is, in the present invention, the chlorine content is 25 to 45 by weight.
% chlorinated polyethylene, low density polyethylene, styrene-butadiene random copolymer, styrene-butadiene block copolymer, styrene-butadiene teleblock copolymer, and ethylene-vinyl acetate copolymer with a vinyl acetate content of 30 wt% or less A medical tube formed by molding a blended polymer with at least one thermoplastic resin selected from the above into a tubular shape, wherein the thermoplastic resin is blended in an amount of 10 to 50 parts by weight per 100 parts by weight of chlorinated polyethylene. , contains virtually no additives, and has an initial elastic modulus of 5Kg/mm 2
The medical tube is characterized in that the curvature at which bending occurs at 0° C. does not change compared to room temperature. Specific Configuration of the Invention The specific configuration of the present invention will be described in detail below. The medical tube of the present invention is made of a polymer blend of chlorinated polyethylene and other thermoplastic resins. The chlorinated polyethylene used in the blend is particularly medium-density to high-density polyethylene that has been chlorinated according to a conventional method. Chlorine is bonded randomly on the polyethylene chain, and the degree of chlorination, that is, the chlorine content, is , in terms of weight ratio, is 25 to 45%, more preferably 30 to 40%. With such a chlorine content, compared to soft polyvinyl chloride, flexibility is further improved, tube bending is significantly reduced, and recovery after deformation is significantly improved. Furthermore, the flexibility and impact resistance at low temperatures are significantly improved compared to soft polyvinyl chloride. The molecular weight of the chlorinated polyethylene used is not particularly limited, but a number average molecular weight of approximately 40,000 to 300,000 may be used. Moreover, there is no particular restriction on its distribution. Further, the density may normally be about 1.00 to 1.25. On the other hand, various thermoplastic resins other than chlorinated polyethylene can be used for blending.
Seeds or more can be used. Among these, polyolefins, olefin copolymers, and styrene copolymers are particularly suitable as the other thermoplastic resins referred to herein. this is,
This is because when one or more of these is blended with the chlorinated polyethylene, extremely favorable properties can be obtained in terms of flexibility and transparency. Among these resins, particularly preferred specific examples include the following. (A) Low-density polyethylene, especially linear low-density polyethylene (LLDPE). Particularly preferred are those having a density of 0.915 to 0.940 and a melt index of 5 g/10 minutes or less based on ASTM D-1238. (B) Ethylene-vinyl acetate copolymer (EVA) Vinyl acetate (VA) content 30wt% or less, especially 5-25wt%, density 0.915-0.95, number average molecular weight 50,000-200,000, melt index 7g/10 Particularly preferred are those of less than 1 minute. (C) Styrene copolymer, especially styrene-butadiene copolymer 1 Styrene-butadiene random copolymer (SBR) Styrene content of about 20-40%, number average molecular weight of about 200,000, Mooney viscosity of about 20-60 is particularly preferred. 2. Styrene-butadiene block copolymer (SB) A soft segment consisting of polybutadiene and polyisoprene, which is block copolymerized with the polybutadiene and a polystyrene hard segment present at the end. In this case, it is preferable to have a density of 0.94 to 0.95 and a melt index of 5 g/10 minutes or less. 3 Styrene-butadiene teleblock copolymer (SBS) A soft segment consisting of polybutadiene, polyisoprene and polyolefin, block copolymerized with these, and polystyrene hard segments present at both ends. In this case, density 0.90 ~
0.94, a melt index of 10 g/10 minutes or less is preferred. The thermoplastic resin other than the chlorinated polyethylene to be blended preferably has a refractive index of about 1.48 to 1.52 from the viewpoint of transparency of the blended polymer. The blending ratio of such chlorinated polyethylene and other thermoplastic resin is preferably 10 to 50 parts by weight of the thermoplastic resin per 100 parts by weight of the chlorinated polyethylene. When the amount is 10 to 50 parts by weight, flexibility and low-temperature properties will be good. In this case, the blending ratio is 100% chlorinated polyethylene
per part by weight, 1 to 100 parts by weight, more preferably
When the amount is 10 to 50 parts by weight, the flexibility and low-temperature properties become even better. Then, they are blended according to a conventional method at such a blending ratio to form a blended polymer. A blended polymer made of such chlorinated polyethylene and other thermoplastic resin is molded into a tubular tube. In this case, the initial elastic modulus of the molded tube is 5 Kg/mm 2 or less. Here, the initial elastic modulus G is determined by JIS K 7113 at the rising edge of the deformation-stress curve in the small deformation range.
Accordingly, G = Wã»l/â³lã»A [where W is the applied load (Kg), l is the initial length (mm), â³l is the elongation (mm), and A is the cross-sectional area (mm 2 ) ]. And when the initial elastic modulus is 5Kg/ mm2 or less,
Flexibility is greatly improved, tube bending is reduced, and recovery is improved. In addition, low-temperature properties, especially flexibility and impact resistance at low temperatures, are improved. In this case, it is preferable that the initial elastic modulus is in the range of 0.1 to 4.0 Kg/mm 2 from the viewpoint of flexibility and the like. In addition, in order to adjust the initial elastic modulus to 5 kg/mm2 or less , the conditions can be easily adjusted by changing the chlorine content, molecular weight, crystallinity of chlorinated polyethylene, or the type and blending ratio of other thermoplastic resins. It can be determined experimentally. Furthermore, from the viewpoint of transparency, the tube preferably has an absorbance of 0.18 to 0.65 at 500 nm per 1 mm thickness. On the other hand, during molding, there is no need to add additives such as plasticizers to the blended polymer.
Therefore, there is almost no elution from the inner wall of the tube. On the other hand, shaping can be carried out by conventional extrusion processing. Therefore, the molding process becomes extremely easy and the cost becomes low. In this case, production becomes easier if dry blending is performed using a screw in an extruder. The tube formed in this way usually has an inner diameter of about 1 to 20 mm and a wall thickness of about 0.3 to 3.5 mm. In addition, it exhibits extremely good flexibility in such dimensions. Note that its cross-sectional shape, dimensions, etc. can be varied. Such medical tubes of the present invention can be used for connection tubes such as infusion sets and blood transfusion sets, tubes for body fluids or blood circuits in various extracorporeal circulation circuits such as dialysis machines and artificial kidneys, tubes for various indwelling needles, various catheters, etc. Furthermore, it is used as a tube for a breathing circuit, etc. These various medical devices are assembled by high-frequency bonding the medical tube of the present invention to other components in a predetermined arrangement, or by performing other desired secondary processing. Specific Effects of the Invention The medical tube of the present invention is made of a blend polymer of chlorinated polyethylene and other thermoplastic resin, and unlike polyvinyl chloride, it does not require the addition of additives such as plasticizers. Very little elution into body fluids, blood, drug solutions, etc. It also exhibits better flexibility than soft polyvinyl chloride. That is, tube bending is extremely rare, and the bending radius of curvature at which tube bending occurs is extremely small compared to polyvinyl chloride. Also,
Restoration properties against deformation are also good; for example, when an incision is caused by a crevice, it restores immediately after the incision is removed, and it also has good followability and resistance to incision, and is more stable than polyvinyl chloride. Excellent flowability. Furthermore, when stored at low temperatures for a long period of time or at low temperatures, polyvinyl chloride loses its flexibility, but the tube of the present invention has less bending and has good constant flow properties. It also has high impact resistance. Such flexibility and low-temperature properties are better than that of chlorinated polyethylene alone. In addition, when performing ethylene oxide gas sterilization as a sterilization process, the degassing rate of the ethylene oxide gas adsorbed after sterilization is lower than that of soft polyvinyl chloride because it does not contain additives such as plasticizers. fast. Furthermore, it is resistant to γ-ray sterilization, and its physical properties remain unchanged. In addition, extrusion processing can be performed well, manufacturing is easy, high-frequency dielectric heating and adhesive bonding are possible, and bonding processing is easy.In addition, various secondary processing when assembling into medical devices is possible. can also be easily done. If chlorinated polyethylene with a chlorine content of 30 to 40% is used, the above flexibility will be even better. The refractive index of the other thermoplastic resin to be blended is
Since the absorbance of the tube at 500 nm is 0.18 to 0.65 per 1 mm thickness, the tube has good transparency when handled as a blood tube. Furthermore, when the tube inner diameter is 2 to 15 mm, the effect of improving bending and constant flow properties is remarkable. In order to confirm the effects of the present invention, the present inventors
Various experiments were conducted. An example is shown below. Experimental Example 1 High-density polyethylene with a number average molecular weight of 100,000 and a density of 0.95 was chlorinated to obtain chlorinated polyethylene (PE-Cl) with a chlorine content of 30% and a density of 1.13. On the other hand, as other thermoplastic resins, the above-mentioned SBS
(Soft segment: polybutadiene, polyisoprene, polyolefin, hard segment: polystyrene, density 0.93, melt index 10
g/10 minutes), the PE-Cl to SBS weight ratio was 80:20, and the mixture was put into the hopper of the extrusion machine and extruded in the screw cylinder.
After blending at 130-190â, the temperature is 190â from the die.
The tube of the present invention was produced by extruding it into a continuous tube having an inner diameter of 3 mm and an outer diameter of 4 mm. Separately, a tube with the same dimensions was similarly prepared from PE-Cl alone. Furthermore, from soft polyvinyl chloride (PVC; Nippon Zeon Co., Ltd. 103EP) containing plasticizers and stabilizers,
Tubes with the same dimensions were also produced by extrusion. In addition, ethylene with a vinyl acetate content of 15wt%
Vinyl acetate copolymer (EVA; manufactured by Toyo Soda Kogyo Co., Ltd.)
Similarly, a tube with the same dimensions was made from UE-630). The initial elastic modulus G of these four types of tubes was measured according to JIS K 7113. The results are shown in Table 1. In addition, in Table 1, the 500 nm wavelength of four types of tubes is
The absorbance of 1 mm thickness is shown.
ãè¡šã
ããã«ããããïŒçš®ã®ããŠãŒãã®æº¶åºç©è©Šéšã
è¡ã€ãã
ããªãã¡ãããŠãŒã15ïœããšãã现çãšããæ°Ž
çŽ150mlã§30åéç
®æ²žããã®ã¡ãæ°Žãå ããŠ150ml
ãšãããããè©Šéšæ¶²ãšããã
ãã®è©Šéšæ¶²10mlã«ã0.01Néãã³ã¬ã³é
žã«ãªãŠ
ã 液20mlãšåžç¡«é
ž1.0mlãå ããïŒåéç
®æ²žåŸå·
åŽããããã«ãšãŠåã«ãªãŠã 0.1ïœãšãã³ãã³è©Š
液ïŒæ»Žãšãå ãã0.01Nããªç¡«é
žãããªãŠã 液ã§
滎å®ããã
ãã©ã³ã¯è©Šéšãšã®éãã³ã¬ã³é
žã«ãªãŠã 液ã®æ¶
è²»éã®å·®ã«ãŠç€ºãéå
æ§ç©è³ªæº¶åºéïŒâ³
KMnO4ïŒãè¡šïŒã«ç€ºãã
ãŸããè©Šéšæ¶²ã«KClãå ããå±æ¹ã«åŸã€ãŠPH枬
å®ãè¡ã€ããšãããè¡šïŒã«ç€ºããããã©ã³ã¯ãšã®
å·®ïŒâ³PHïŒãåŸãããã
ããã«ããããããŠãŒã0.5ïœãçšããã«ãŒã
ç¶ãšããçè¡ãã¿ãããïŒæéæ¯ãšããã溶è¡è©Š
éšãè¡ã€ãã溶è¡ã®çºçãè¡šäžïŒããã³âã§ç€º
ãã[Table] Furthermore, eluate tests for these four tubes were conducted. In other words, take 15g of the tube, cut it into small pieces, boil it in about 150ml of water for 30 minutes, then add water to make 150ml.
This was used as the test solution. To 10 ml of this test solution, add 20 ml of 0.01N potassium permanganate solution and 1.0 ml of dilute sulfuric acid, boil for 3 minutes, cool, add 0.1 g of potassium iodide and 5 drops of starch test solution, and add 0.01N sodium thiosulfate. Titrated with liquid. The amount of reducing substances eluted (â³
KMnO 4 ) is shown in Table 2. In addition, when KCl was added to the test solution and PH was measured according to the pharmacopoeia, the difference (â³PH) from the blank shown in Table 2 was obtained. Furthermore, these 0.5 m tubes were made into a loop shape, filled with bovine blood, and shaken for 1 hour to perform a hemolysis test. The occurrence of hemolysis is indicated by + and - in the table.
ãè¡šã
è¡šïŒã«ç€ºãããçµæãããæ¬çºæã®ããŠãŒãã¯
溶è¡éãããããŠå°ãªãããšããããã
ãããšã¯å¥ã«ãäžèšã®ãããªå¯ãšãæ§è©Šéšãè¡
ã€ãã
ãŸããïŒçš®ã®ããŠãŒãã«ã€ãããããåçš®ã®åŸ
ãæããåæ±äžã«å·»ãã€ããæãã®çããæ²çå
åŸã枬å®ãããïŒâããã³20âã«ããã枬å®çµæ
ãè¡šïŒã«ç€ºãã
ãŸããããŠãŒããïŒïœé·ãšããäžæ¹ç«¯ã«ãã€ã³
ããŒãšã³ãéããšãã€ããä»ç«¯ã«ãŽã 管ãšã¿ã³ç®¡
ãšãä»ãéããšãã€ããããŠãŒãäžå€®ã«ããŒã©ãŒ
ã¯ã¬ã³ã¡ãä»ããããã®ããŠãŒãã«ã600mmH2O
ã«ãŠãæ°Žéæ°ŽãæµããããŒã©ãŒã¯ã¬ã³ã¡ã«ããã
æµéãçŽïŒmlïŒåã«èª¿ç¯ããæµãå§ãã®æµéQ0
ã«å¯Ÿããã30ååŸã®æµéQ1ã枬å®ããå®æµéæ§
ãè©äŸ¡ãããçµæãè¡šïŒã«ç€ºãã[Table] From the results shown in Table 2, it can be seen that the tube of the present invention has an extremely small amount of hemolysis. Separately, the following flexibility test was conducted. First, four types of tubes were wound around cylinders having various diameters, and the radius of curvature at which bending occurred was measured. Table 3 shows the measurement results at 0°C and 20°C. Further, the tube was made 1 m long, a chamber and a bottle needle were attached to one end, a needle was attached to the other end via a rubber tube and an octopus tube, and a roller crease was attached to the center of the tube. In this tube, 600mmH 2 O
, run tap water and use a roller cleanser.
Adjust the flow rate to approximately 5 ml/min, and set the flow rate at the beginning of the flow to Q 0.
Flow rate Q 1 after 30 minutes was measured to evaluate constant flow performance. The results are shown in Table 3.
ãè¡šã
è¡šïŒã®çµæãããæ¬çºæã®ããŠãŒãã¯ãããã
ãŠå¯ãšãæ§ãšäœæž©ç¹æ§ã«ããããŠããããšããã
ãã
ããã«ãããããšã¯å¥ã«ããšãã¬ã³ãªããµã€ã
ã¬ã¹æ»
èãè¡ããæ»
èåŸã®ãšãã¬ã³ãªããµã€ãæ®
åéããã¬ã¹ã¯ãããã°ã©ãæ³ã«ãŠæž¬å®ããã
çµæãè¡šïŒã«ç€ºãã
ãŸããγâç·æ»
èãè¡ããæ»
èåŸã®äžèšâ³PHã®
å€åçãéãã³ã¬ã³é
žæ¶è²»è©Šéšå€ïŒâ³KMnO4ïŒ
ã®å€åçããã³ã·ãšã¢ãŒïŒ€ç¡¬åºŠã®å€åéã枬å®ã
ãã
çµæãè¡šïŒã«ç€ºãã[Table] From the results in Table 3, it can be seen that the tube of the present invention has extremely excellent flexibility and low-temperature properties. Furthermore, apart from these, ethylene oxide gas sterilization was performed, and the residual amount of ethylene oxide after sterilization was measured by gas chromatography. The results are shown in Table 4. In addition, γ-ray sterilization was performed, and the rate of change in the above â³PH after sterilization, permanganate consumption test value (â³KMnO 4 )
The rate of change in Shore D hardness and the amount of change in Shore D hardness were measured. The results are shown in Table 4.
ãè¡šã
è¡šïŒã«ç€ºãããçµæãããæ¬çºæã®ããŠãŒã
ã¯ããšãã¬ã³ãªããµã€ãã¬ã¹ããã³Î³âç·æ»
èçž
æ¹ã«å¯ŸããããããŠé«ãé©åæ§ãªããèæ§ããã€
ãŠããããšããããããã®å Žåãç¹ã«ãšãã¬ã³ãª
ããµã€ãæ®åéãšãγâç·æ»
èåŸã®â³PHã®å€å
ã¯ãå¡©çŽ åããªãšãã¬ã³ãåç¬ã§çšãããšãã
ããæ Œæ®µãšè¯å¥œãªçµæã瀺ãã
ãªããç¹éæ56â23959å·å
¬å ±ã«ã¯ãæ¬çºæãš
ç°ãªããæ·»å å€ãå«ãå¡©çŽ åããªãšãã¬ã³ã®ããŠ
ãŒããèšèŒãããŠãããããããåå
¬å ±èšèŒã®å®
æœäŸïŒã®ãã®ãé«æž©é«æ¹¿äžã«ä¿åãããšãããã
ãŠãŒããå€è²ããã
ããã«å¯Ÿããæ¬çºæã®ãã®ã¯å
šãåžå
床ã«å€å
ããªãã€ãã
ãªããåå
¬å ±å®æœäŸïŒã®ãã®ã¯å¡©çŽ åããªãšã
ã¬ã³ïŒããªãšãã¬ã³ååé16äžããã³ïŒäžãå¡©çŽ
å«é34ïŒ
ïŒ100éééšã«ãã¹ãã¢ãªã³é
žã«ã«ã·ãŠ
ã ãšã¹ãã¢ãªã³é
žäºéïŒéééšãããªãšãã¬ã³ã¯
ãã¯ã¹0.15éééšããšããã·ãå倧è±æ²¹ïŒéééš
ãšãããªããã®ã§ããã
å®éšäŸ ïŒ
äžèšè¡šïŒã«ç€ºãããããã«ãPEâClã®å¡©çŽ å«
æéãšãç±å¯å¡æ§æš¹èã®çš®é¡ãšããã¬ã³ãé
åæ¯
ãšããããåæ匟æ§çã®ç°ãªãåããŠãŒãããå®
éšäŸïŒãšåæ§ã«ããããšåäžå¯žæ³ã«ãŠäœè£œããã
ãããåããŠãŒãã®ç¹æ§ãè¡šïŒã«ç€ºãã
ãªããçšããPEâClã®æ°å¹³åååéã¯10äžã
30äžçšåºŠãšããããŸããçšããç±å¯å¡æ§æš¹èã¯äž
èšã®ãšããã§ããã
SBSïŒåèšå®éšäŸïŒã®ãšãã
EVAïŒVAå«æé25wtïŒ
ãå¯åºŠ0.95 ã¡ã«ãã»ã€
ã³ããã¯ã¹ïŒïœïŒ10åãå¹³åååéçŽ10äž
LLDPEïŒå¯åºŠ0.92 ã¡ã«ãã»ã€ã³ããã¯ã¹ïŒ
ïœïŒ10å
SBRïŒã¹ãã¬ã³éçŽ30wtïŒ
ã ãŒããŒç²åºŠ40
SBïŒå¯åºŠ0.94 ã¡ã«ãã»ã€ã³ããã¯ã¹2.6ïœïŒ10
å
ãªããåããŠãŒããšããâ³ïŒKMnO4ïŒãâ³PH
ãªãã³ã«ããšãã¬ã³ãªããµã€ãã¬ã¹ããã³Î³âç·
æ»
èåŸã®è©Šéšçµæã¯ãå®æœäŸïŒã«ããããšã»ãŒå
çã§ãã€ãã[Table] From the results shown in Table 4, it can be seen that the tube of the present invention has extremely high compatibility or resistance to ethylene oxide gas and gamma ray sterilization partners. In this case, in particular, the residual amount of ethylene oxide and the change in ÎPH after γ-ray sterilization show much better results than when chlorinated polyethylene is used alone. Note that, unlike the present invention, JP-A-56-23959 describes a chlorinated polyethylene tube containing additives. However, when the tube of Example 1 described in the same publication was stored under high temperature and high humidity, the tube changed color. In contrast, in the case of the present invention, there was no change in absorbance at all. In addition, Example 1 of the same publication contains 100 parts by weight of chlorinated polyethylene (polyethylene molecular weight 160,000 and 30,000, chlorine content 34%), 2 parts by weight of calcium stearate and zinc stearate, 0.15 parts by weight of polyethylene wax, and epoxide. It consists of 5 parts by weight of hydrogenated soybean oil. Experimental Example 2 As shown in Table 5 below, the chlorine content of PE-Cl, the type of thermoplastic resin, and the blending ratio were changed, and tubes with different initial elastic moduli were prepared in the same manner as in Experimental Example 1. , was manufactured with the same dimensions as that. Table 5 shows the characteristics of each of these tubes. The number average molecular weight of PE-Cl used was 100,000~
It was set at around 300,000. Moreover, the thermoplastic resin used is as follows. SBS: As in Experimental Example 1 above EVA: VA content 25wt%, density 0.95 Melt index 2g/10 min, average molecular weight approximately 100,000 LLDPE; Density 0.92 Melt index 4
g/10 min SBR; Styrene amount approx. 30 wt% Mooney viscosity 40 SB; Density 0.94 Melt index 2.6 g/10
In addition, for each tube, â³(KMnO 4 ), â³PH
In addition, the test results after ethylene oxide gas and γ-ray sterilization were almost the same as in Example 1.
ãè¡šã
è¡šïŒã«ç€ºãããçµæãããå¡©çŽ åããªãšãã¬ã³
ã®å¡©çŽ å«æéã25ã45ïŒ
ãšãªããåæ匟æ§çãïŒ
KgïŒmm2以äžãšãªããšãããããŠããããå¯ãšãæ§
ãšäœæž©ç¹æ§ãšã瀺ãããããšããããã[Table] From the results shown in Table 5, the chlorine content of chlorinated polyethylene is 25 to 45%, and the initial elastic modulus is 5.
It can be seen that when it is less than Kg/mm 2 , extremely excellent flexibility and low-temperature properties are exhibited.
Claims (1)
ãã¬ã³ãšãäœå¯åºŠããªãšãã¬ã³ãã¹ãã¬ã³âãã¿
ãžãšã³ã©ã³ãã å ±éåäœãã¹ãã¬ã³âãã¿ãžãšã³
ãããã¯å ±éåäœãã¹ãã¬ã³âãã¿ãžãšã³ãã¬ã
ããã¯å ±éåäœããã³é ¢é žããã«å«æé30wtïŒ
以äžã®ãšãã¬ã³âé ¢é žããã«å ±éåäœããéžã°ã
ãå°ãªããšãïŒã€ã®ç±å¯å¡æ§æš¹èãšã®ãã¬ã³ãã
ãªããŒã管ç¶ã«æ圢ããŠãªãå»çšããŠãŒãã§ãã€
ãŠã å¡©çŽ åããªãšãã¬ã³100éééšããã10ã50é
ééšã®åèšç±å¯å¡æ§æš¹èãé åããŠãªããå®è³ªç
ã«æ·»å å€ãå«ãŸãããããåæ匟æ§çãïŒKgïŒmm2
以äžã§ããã€åžžæž©ã«æ¯ããŠïŒâã§ã®æãã®çãã
æ²çãå€åããªãç©æ§ã§ããããšãç¹åŸŽãšããå»
çšããŠãŒãã ïŒ ç±å¯å¡æ§æš¹èã®å±æçã1.48ã1.52ã§ããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®å»çšããŠãŒãã ïŒ ããŠãŒãã®500nïœã«ãããåžå 床ããïŒmm
ãããã0.18ã0.65ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ãŸãã¯ç¬¬ïŒé ã«èšèŒã®å»çšããŠãŒãã ïŒ ããŠãŒãå åŸãïŒã20mmã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé ãªãã第ïŒé ã®ããããã«èšèŒã®å»çšã
ãŠãŒãã[Scope of Claims] 1. Chlorinated polyethylene with a chlorine content of 25 to 45% by weight, low density polyethylene, styrene-butadiene random copolymer, styrene-butadiene block copolymer, styrene-butadiene teleblock copolymer Combined and vinyl acetate content 30wt%
A medical tube formed by molding a blended polymer with at least one thermoplastic resin selected from the following ethylene-vinyl acetate copolymers into a tubular shape, comprising 10 to 50 parts by weight of the above per 100 parts by weight of chlorinated polyethylene. Contains thermoplastic resin, contains virtually no additives, and has an initial elastic modulus of 5Kg/mm 2
A medical tube characterized in that the curvature at which a bend occurs does not change at 0° C. compared to room temperature. 2. The medical tube according to claim 1, wherein the thermoplastic resin has a refractive index of 1.48 to 1.52. 3 The absorbance of the tube at 500nm is 1mm
2. The medical tube according to claim 1 or 2, wherein the average diameter is 0.18 to 0.65. 4. The medical tube according to any one of claims 1 to 3, wherein the tube has an inner diameter of 1 to 20 mm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56173638A JPS5875554A (en) | 1981-10-29 | 1981-10-29 | Medical tube |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56173638A JPS5875554A (en) | 1981-10-29 | 1981-10-29 | Medical tube |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5875554A JPS5875554A (en) | 1983-05-07 |
JPH025426B2 true JPH025426B2 (en) | 1990-02-02 |
Family
ID=15964311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56173638A Granted JPS5875554A (en) | 1981-10-29 | 1981-10-29 | Medical tube |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5875554A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5623959A (en) * | 1979-04-10 | 1981-03-06 | Hoechst Ag | Therapeutic device for liquid of extraaintestine |
JPS573653A (en) * | 1980-06-09 | 1982-01-09 | Sumitomo Bakelite Co | Medical tool in vinyl chloride group resin |
-
1981
- 1981-10-29 JP JP56173638A patent/JPS5875554A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5623959A (en) * | 1979-04-10 | 1981-03-06 | Hoechst Ag | Therapeutic device for liquid of extraaintestine |
JPS573653A (en) * | 1980-06-09 | 1982-01-09 | Sumitomo Bakelite Co | Medical tool in vinyl chloride group resin |
Also Published As
Publication number | Publication date |
---|---|
JPS5875554A (en) | 1983-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1155578A (en) | Thermoplastic elastomeric block copolymer balloon-type catheters | |
JP5338315B2 (en) | Catheter tube and catheter comprising the same | |
US6977105B1 (en) | Multilayered tube and medical supply comprising multilayered tube | |
JP2550256B2 (en) | Medical bag | |
JP5632226B2 (en) | Medical multilayer tube and medical infusion bag | |
JPS5974153A (en) | Resin composition | |
EP0969884B1 (en) | Low modulus and autoclavable monolayer medical tubing | |
JPH11505188A (en) | Medical tubes and assemblies | |
JPWO2009054524A1 (en) | Balloon resin composition and balloon comprising the same | |
JPH025426B2 (en) | ||
JP2005198858A (en) | Multilayer tube for medical treatment | |
JPS5829338B2 (en) | Resin composition for medical equipment construction | |
JP6106156B2 (en) | Manufacturing method of medical multilayer tube | |
JP2003205033A (en) | Base material for conveyance and preservation of medical solution | |
JP2007236782A (en) | Medical tube | |
JPS5875553A (en) | Medical tube | |
JP4754180B2 (en) | Medical tube | |
JP2894793B2 (en) | Platelet storage bag | |
JP3328367B2 (en) | Antithrombotic catheter | |
JP2001252348A (en) | Tube for medical treatment | |
JPH1170162A (en) | Polymer material for production of medical equipment | |
JPS6254348B2 (en) | ||
JPS5968362A (en) | Thermoplastic resin composition | |
JPH02231139A (en) | Composite film | |
KR20150136362A (en) | Non-pvc hose for medical solution set |